Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Inflammatory Breast Carcinoma
Interventions: DRUG: 89Zr-bevacizumab|PROCEDURE: FDG-PET/CT|PROCEDURE: MRI scan|PROCEDURE: Tumor biopsies
Sponsor: Dana-Farber Cancer Institute
Collaborators: National Cancer Institute (NCI)